SG11201400484RA - Novel heterocyclic derivatives and their uses - Google Patents
Novel heterocyclic derivatives and their usesInfo
- Publication number
- SG11201400484RA SG11201400484RA SG11201400484RA SG11201400484RA SG11201400484RA SG 11201400484R A SG11201400484R A SG 11201400484RA SG 11201400484R A SG11201400484R A SG 11201400484RA SG 11201400484R A SG11201400484R A SG 11201400484RA SG 11201400484R A SG11201400484R A SG 11201400484RA
- Authority
- SG
- Singapore
- Prior art keywords
- heterocyclic derivatives
- novel heterocyclic
- novel
- derivatives
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20110100369 | 2011-09-30 | ||
KR20120033444 | 2012-03-30 | ||
PCT/KR2012/007965 WO2013048214A2 (en) | 2011-09-30 | 2012-09-28 | Novel heterocyclic derivatives and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201400484RA true SG11201400484RA (en) | 2014-10-30 |
Family
ID=47996667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201400484RA SG11201400484RA (en) | 2011-09-30 | 2012-09-28 | Novel heterocyclic derivatives and their uses |
Country Status (26)
Country | Link |
---|---|
US (1) | US9586959B2 (en) |
EP (2) | EP2760865B1 (en) |
JP (1) | JP6031107B2 (en) |
KR (1) | KR101800749B1 (en) |
CN (1) | CN103889986B (en) |
AR (1) | AR088085A1 (en) |
AU (1) | AU2012316912B9 (en) |
BR (1) | BR112014007645A2 (en) |
CA (1) | CA2848154C (en) |
CY (1) | CY1121292T1 (en) |
DK (2) | DK2760865T3 (en) |
ES (2) | ES2687693T3 (en) |
FI (1) | FI3461825T3 (en) |
HR (2) | HRP20230893T1 (en) |
HU (2) | HUE062842T2 (en) |
LT (2) | LT2760865T (en) |
MX (1) | MX355795B (en) |
PL (2) | PL3461825T3 (en) |
PT (2) | PT3461825T (en) |
RS (2) | RS57854B1 (en) |
RU (1) | RU2628074C2 (en) |
SG (1) | SG11201400484RA (en) |
SI (2) | SI2760865T1 (en) |
TR (1) | TR201814710T4 (en) |
TW (1) | TWI551600B (en) |
WO (1) | WO2013048214A2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112016000059B1 (en) | 2013-07-02 | 2020-12-29 | Syngenta Participations Ag | bi or tricyclic heterocycles compounds, composition comprising said compounds, method for combating and controlling pests, method for protecting plant propagation material from attack by pests and plant propagation material coated with said composition |
CN103435561B (en) * | 2013-08-19 | 2016-08-10 | 上海交通大学 | A kind of Novel D-amino acid oxidase inhibitor and preparation thereof and application |
CN104016909B (en) * | 2014-04-03 | 2016-04-20 | 定陶县友帮化工有限公司 | The synthetic method of the bromo-5-chloropyridine of a kind of 2-amino-3- |
CN104016911A (en) * | 2014-04-03 | 2014-09-03 | 定陶县友帮化工有限公司 | Synthetic method of 2-amino-3,5-dibromopyridine |
CN106187793A (en) * | 2016-01-26 | 2016-12-07 | 赵鸣 | 5 aminolevulinic acids and the salt compound of derivant thereof and application |
CN109789143A (en) | 2016-07-01 | 2019-05-21 | G1治疗公司 | Antiproliferative based on pyrimidine |
US10905675B2 (en) | 2016-12-14 | 2021-02-02 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for prevention, alleviation or treatment of pruritus |
US11028090B2 (en) | 2017-01-26 | 2021-06-08 | Dong Wha Pharm. Co., Ltd. | [1,2,4]Triazolo[4,3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating BET protein-related diseases, containing same as active ingredient |
CA3054455C (en) * | 2017-02-27 | 2021-10-26 | Betta Pharmaceuticals Co., Ltd | Fgfr inhibitor and application thereof |
TW202021969A (en) * | 2018-05-31 | 2020-06-16 | 南韓商C&C新藥研究所 | Heterocyclic derivatives and use thereof |
GB2575490A (en) * | 2018-07-12 | 2020-01-15 | Recordati Ind Chimica E Farmaceutica Spa | P2X3 receptor antagonists |
US11718622B2 (en) | 2020-03-16 | 2023-08-08 | Exelixis Inc. | Heterocyclic adenosine receptor antagonists |
CN115698014A (en) | 2020-05-19 | 2023-02-03 | G1治疗公司 | Cyclin dependent kinase inhibiting compounds for the treatment of medical conditions |
EP4067357A1 (en) * | 2021-03-30 | 2022-10-05 | JW Pharmaceutical Corporation | Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine hydrogen sulfate monohydrate |
TW202317568A (en) | 2021-06-22 | 2023-05-01 | 丹麥商理奧藥品公司 | Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine hemisuccinate |
WO2024068851A1 (en) | 2022-09-29 | 2024-04-04 | Jw Pharmaceutical Corporation | A process for the manufacture of salts and crystalline forms of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine and novel crystalline forms |
WO2024069577A1 (en) * | 2022-09-29 | 2024-04-04 | Jw Pharmaceutical Corporation | Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine |
WO2024069576A1 (en) * | 2022-09-30 | 2024-04-04 | Jw Pharmaceutical Corporation | Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine mono succinate |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4831013A (en) * | 1986-03-20 | 1989-05-16 | Ciba-Geigy Corporation | 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines, pharmaceutical compositions, and uses thereof |
US5070086A (en) | 1987-12-23 | 1991-12-03 | Schering Corporation | Imidazo- and pyrimido-quinoline, naphthyridine and pyridopyrazine compounds |
US6451796B1 (en) * | 1997-11-11 | 2002-09-17 | Ono Pharmaceutical Co., Ltd. | Fused pyrazine compounds |
WO1999045009A1 (en) | 1998-03-04 | 1999-09-10 | Bristol-Myers Squibb Company | Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
JP2000119271A (en) | 1998-08-12 | 2000-04-25 | Hokuriku Seiyaku Co Ltd | 1h-imidazopyridine derivative |
JP2000319277A (en) * | 1999-05-11 | 2000-11-21 | Ono Pharmaceut Co Ltd | Condensed pyrazine compound and medicinal agent having the same as active ingredient |
CA2520251A1 (en) | 2003-03-27 | 2004-10-07 | Pfizer Products Inc. | Substituted 4-amino[1,2,4]triazolo[4,3-a]quinoxalines |
US20090075980A1 (en) * | 2003-10-03 | 2009-03-19 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and Analogs Thereof |
WO2009068246A2 (en) * | 2007-11-30 | 2009-06-04 | Elbion Gmbh | Methods of treating obesity and metabolic disorders |
CA2716706C (en) * | 2008-03-03 | 2014-02-18 | Irm Llc | Compounds and compositions as tlr activity modulators |
EP2324029A4 (en) | 2008-09-10 | 2011-09-14 | Kalypsys Inc | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
CN100580335C (en) * | 2008-09-11 | 2010-01-13 | 艾欧史密斯(中国)热水器有限公司 | Pressure bearing type solar water heater |
EP2367821B1 (en) * | 2008-12-17 | 2015-09-16 | Merck Patent GmbH | C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof |
SG172958A1 (en) * | 2009-01-23 | 2011-08-29 | Takeda Pharmaceutical | Poly (adp-ribose) polymerase (parp) inhibitors |
JP5715625B2 (en) * | 2009-07-30 | 2015-05-07 | 武田薬品工業株式会社 | Poly (ADP-ribose) polymerase (PARP) inhibitor |
GB0919423D0 (en) * | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
EP2509983B1 (en) | 2009-11-16 | 2014-09-17 | Merck Sharp & Dohme Corp. | FUSED TRICYCLIC COMPOUNDS WITH ADENOSINE A2a RECEPTOR ANTAGONIST ACTIVITY |
TW201204727A (en) * | 2010-03-10 | 2012-02-01 | Kalypsys Inc | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
-
2012
- 2012-09-28 ES ES12834688.9T patent/ES2687693T3/en active Active
- 2012-09-28 LT LTEP12834688.9T patent/LT2760865T/en unknown
- 2012-09-28 EP EP12834688.9A patent/EP2760865B1/en active Active
- 2012-09-28 FI FIEP18180710.8T patent/FI3461825T3/en active
- 2012-09-28 CA CA2848154A patent/CA2848154C/en active Active
- 2012-09-28 DK DK12834688.9T patent/DK2760865T3/en active
- 2012-09-28 LT LTEP18180710.8T patent/LT3461825T/en unknown
- 2012-09-28 RU RU2014115478A patent/RU2628074C2/en active
- 2012-09-28 RS RS20181171A patent/RS57854B1/en unknown
- 2012-09-28 MX MX2014003042A patent/MX355795B/en active IP Right Grant
- 2012-09-28 HR HRP20230893TT patent/HRP20230893T1/en unknown
- 2012-09-28 TR TR2018/14710T patent/TR201814710T4/en unknown
- 2012-09-28 SI SI201231387T patent/SI2760865T1/en unknown
- 2012-09-28 TW TW101135774A patent/TWI551600B/en active
- 2012-09-28 JP JP2014533218A patent/JP6031107B2/en active Active
- 2012-09-28 AU AU2012316912A patent/AU2012316912B9/en active Active
- 2012-09-28 DK DK18180710.8T patent/DK3461825T3/en active
- 2012-09-28 AR ARP120103614A patent/AR088085A1/en active IP Right Grant
- 2012-09-28 PT PT181807108T patent/PT3461825T/en unknown
- 2012-09-28 SI SI201232039T patent/SI3461825T1/en unknown
- 2012-09-28 EP EP18180710.8A patent/EP3461825B1/en active Active
- 2012-09-28 ES ES18180710T patent/ES2954303T3/en active Active
- 2012-09-28 SG SG11201400484RA patent/SG11201400484RA/en unknown
- 2012-09-28 PT PT12834688T patent/PT2760865T/en unknown
- 2012-09-28 HU HUE18180710A patent/HUE062842T2/en unknown
- 2012-09-28 WO PCT/KR2012/007965 patent/WO2013048214A2/en active Application Filing
- 2012-09-28 RS RS20230629A patent/RS64575B1/en unknown
- 2012-09-28 KR KR1020147010409A patent/KR101800749B1/en active IP Right Grant
- 2012-09-28 PL PL18180710.8T patent/PL3461825T3/en unknown
- 2012-09-28 HU HUE12834688A patent/HUE040374T2/en unknown
- 2012-09-28 PL PL12834688T patent/PL2760865T3/en unknown
- 2012-09-28 CN CN201280051950.6A patent/CN103889986B/en active Active
- 2012-09-28 BR BR112014007645A patent/BR112014007645A2/en not_active Application Discontinuation
- 2012-09-28 US US14/347,950 patent/US9586959B2/en active Active
-
2018
- 2018-08-13 HR HRP20181310TT patent/HRP20181310T1/en unknown
- 2018-10-09 CY CY20181101040T patent/CY1121292T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181310T1 (en) | Novel heterocyclic derivatives and their uses | |
HK1199725A1 (en) | Heterocyclic compounds and uses thereof | |
HK1198475A1 (en) | Heterocyclic compounds and uses thereof | |
HK1198443A1 (en) | Heterocyclic compounds and uses thereof | |
HK1193561A1 (en) | Heterocyclic compounds and uses thereof | |
HK1207069A1 (en) | Heterocyclic compounds and uses thereof | |
HK1198433A1 (en) | N-acyldipeptide derivatives and their uses n- | |
IL227664A0 (en) | Novel heterocyclic derivatives | |
IL222288A0 (en) | Heterocyclic compounds and their uses | |
AP4055A (en) | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | |
IL233311A0 (en) | Heteroarylpiperidine and piperazine derivatives as fungicides | |
AP3611A (en) | Heterocyclic compounds and their uses | |
HK1198833A1 (en) | N-acylpeptide derivatives and their uses n- | |
EP2782571A4 (en) | Heterocyclic compounds and uses thereof |